Coherus BioSciences, Inc is a biotechnology business based in the US. Coherus BioSciences shares (CHRS) are listed on the NASDAQ and all prices are listed in US Dollars. Coherus BioSciences employs 310 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Coherus BioSciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CHRS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Coherus BioSciences stock price (NASDAQ: CHRS)Use our graph to track the performance of CHRS stocks over time.
Coherus BioSciences shares at a glance
|Latest market close||$13.55|
|52-week range||$12.66 - $22.22|
|50-day moving average||$13.85|
|200-day moving average||$15.33|
|Wall St. target price||$25.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.62|
Buy Coherus BioSciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Coherus BioSciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Coherus BioSciences price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-6.81%|
|3 months (2021-04-28)||-8.20%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Is Coherus BioSciences under- or over-valued?
Valuing Coherus BioSciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Coherus BioSciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Coherus BioSciences's EBITDA
Coherus BioSciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $159.2 million.
The EBITDA is a measure of a Coherus BioSciences's overall financial performance and is widely used to measure a its profitability.
Coherus BioSciences financials
|Revenue TTM||$442.7 million|
|Gross profit TTM||$295.4 million|
|Return on assets TTM||-5.25%|
|Return on equity TTM||-53.54%|
|Market capitalisation||$960.5 million|
TTM: trailing 12 months
Shorting Coherus BioSciences shares
There are currently 9.5 million Coherus BioSciences shares held short by investors – that's known as Coherus BioSciences's "short interest". This figure is 1.9% down from 9.7 million last month.
There are a few different ways that this level of interest in shorting Coherus BioSciences shares can be evaluated.
Coherus BioSciences's "short interest ratio" (SIR)
Coherus BioSciences's "short interest ratio" (SIR) is the quantity of Coherus BioSciences shares currently shorted divided by the average quantity of Coherus BioSciences shares traded daily (recently around 806213.55932203). Coherus BioSciences's SIR currently stands at 11.8. In other words for every 100,000 Coherus BioSciences shares traded daily on the market, roughly 11800 shares are currently held short.
However Coherus BioSciences's short interest can also be evaluated against the total number of Coherus BioSciences shares, or, against the total number of tradable Coherus BioSciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Coherus BioSciences's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Coherus BioSciences shares in existence, roughly 130 shares are currently held short) or 0.1519% of the tradable shares (for every 100,000 tradable Coherus BioSciences shares, roughly 152 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Coherus BioSciences.
Find out more about how you can short Coherus BioSciences stock.
Coherus BioSciences share dividends
We're not expecting Coherus BioSciences to pay a dividend over the next 12 months.
Coherus BioSciences share price volatility
Over the last 12 months, Coherus BioSciences's shares have ranged in value from as little as $12.66 up to $22.2166. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Coherus BioSciences's is 1.0686. This would suggest that Coherus BioSciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Coherus BioSciences overview
Coherus BioSciences, Inc. , a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline includes biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar; and CHS-131, a once-daily oral drug candidate for non-alcoholic steatohepatitis and other metabolic conditions. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.
Stocks similar to Coherus BioSciences
Coherus BioSciences in the news
Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th
Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th
Coherus Biosciences price target raised to $36 from $26 at H.C. Wainwright
Frequently asked questionsWhat percentage of Coherus BioSciences is owned by insiders or institutions?
Currently 1.381% of Coherus BioSciences shares are held by insiders and 110.888% by institutions. How many people work for Coherus BioSciences?
Latest data suggests 310 work at Coherus BioSciences. When does the fiscal year end for Coherus BioSciences?
Coherus BioSciences's fiscal year ends in December. Where is Coherus BioSciences based?
Coherus BioSciences's address is: 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065 What is Coherus BioSciences's ISIN number?
Coherus BioSciences's international securities identification number is: US19249H1032 What is Coherus BioSciences's CUSIP number?
Coherus BioSciences's Committee on Uniform Securities Identification Procedures number is: 19249H103
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert